Novartis(DE:NOTA)
€143.00-2.00 (-1.38%)
DE:NOTA
Novartis earnings date
€143.00
At close:-2.00 (-1.38%)
Novartis (NOTA) Q1 2026 Earnings Report
27 Followers
DE:NOTA Q1 2026 EPS Results
- Actual EPS
- EUR 1.77
- Consensus EPS
- EUR 1.86
- Beat/Miss
- Missed by -EUR 0.10
- One Year Ago EPS
- EUR 2.03
DE:NOTA Q1 2026 Revenue Results
- Actual Revenue
- EUR 11.70B
- Expected Revenue
- EUR 11.94B
- Beat/Miss
- Missed by -EUR 242.70M
- YoY Revenue Growth
- -0.59%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 04/28/2026
- Time
- Before Open
- Conference Call
- Tuesday, April 28, 2026
DE:NOTA Upcoming Earnings
Novartis's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
DE:NOTA Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:NOTA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 2.00- | 1.8 | ― | ― |
| Oct 27, 2026 | 2026 (Q3) | 2.022.19 | 2 | 9.33% (+0.19) | |
| Jul 21, 2026 | 2026 (Q2) | 1.932.14 | 2.15 | -0.41% (-0.01) | |
| Apr 28, 2026 | 2026 (Q1) | 1.861.77 | 2.03 | -12.72% (-0.26) | |
| Feb 04, 2026 | 2025 (Q4) | 1.761.80 | 1.76 | 2.53% (+0.04) | |
| Oct 28, 2025 | 2025 (Q3) | 2.022.00 | 1.83 | 9.22% (+0.17) | |
| Jul 17, 2025 | 2025 (Q2) | 2.092.15 | 1.75 | 22.84% (+0.40) | |
| Apr 29, 2025 | 2025 (Q1) | 1.882.03 | 1.6 | 26.67% (+0.43) | |
| Jan 31, 2025 | 2024 (Q4) | 1.601.76 | 1.36 | 29.41% (+0.40) | |
| Oct 29, 2024 | 2024 (Q3) | 1.721.83 | 1.55 | 18.39% (+0.28) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
